Clinical Trial Update: The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three doses of live attenuated oral rotavirus vaccine 116E for rotavirus gastroenteritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• 116E (live attenuated oral rotavirus vaccine)

Snippet

Sponsor: University of Chile | Conditions: Rotavirus Gastroenteritis | Phase 3 | Status: UNKNOWN